Oral contraception and menstrual bleeding during treatment of venous thromboembolism: expert opinion versus current practice : combined results of a systematic review, expert panel opinion and an international survey
Introduction: The optimal management of oral contraception and menstrual bleeding during treatment of venous thromboembolism (VTE) is largely unknown. We aimed to elicit expert opinion and compare that to current practice as assessed by a world-wide international web-based survey among physicians. M...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
20 March 2017
|
| In: |
Thrombosis research
Year: 2017, Jahrgang: 153, Pages: 101-107 |
| ISSN: | 1879-2472 |
| DOI: | 10.1016/j.thromres.2017.03.013 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1016/j.thromres.2017.03.013 Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0049384817302372 
|
| Verfasserangaben: | F.A. Klok, K. Schreiber, K. Stach, W. Ageno, S. Middeldorp, S. Eichinger, A. Delluc, M. Blondon, C. Ay |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 158128652X | ||
| 003 | DE-627 | ||
| 005 | 20220815020502.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180925s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.thromres.2017.03.013 |2 doi | |
| 035 | |a (DE-627)158128652X | ||
| 035 | |a (DE-576)51128652X | ||
| 035 | |a (DE-599)BSZ51128652X | ||
| 035 | |a (OCoLC)1341018569 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Klok, Erik |e VerfasserIn |0 (DE-588)1167807111 |0 (DE-627)1031307567 |0 (DE-576)511285590 |4 aut | |
| 245 | 1 | 0 | |a Oral contraception and menstrual bleeding during treatment of venous thromboembolism |b expert opinion versus current practice : combined results of a systematic review, expert panel opinion and an international survey |c F.A. Klok, K. Schreiber, K. Stach, W. Ageno, S. Middeldorp, S. Eichinger, A. Delluc, M. Blondon, C. Ay |
| 264 | 1 | |c 20 March 2017 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 20 March 2017 | ||
| 500 | |a Gesehen am 25.09.2018 | ||
| 520 | |a Introduction: The optimal management of oral contraception and menstrual bleeding during treatment of venous thromboembolism (VTE) is largely unknown. We aimed to elicit expert opinion and compare that to current practice as assessed by a world-wide international web-based survey among physicians. Methods: 10 international thrombosis experts and 10 abnormal uterine bleeding experts independently completed a questionnaire containing three hypothetical patient cases each with four different scenarios, and additional queries covering different severities of VTE, patient circumstances, hormonal contraceptives and both thrombotic and bleeding complications. The consensus percentage was set a priori at ≥70%. The same questionnaire with randomized case scenarios was presented to international physicians via newsletters of the ISTH and national scientific communities. Differences between the expert groups and daily clinical care were assessed. Results: Expert recommendations were divergent and differed in several important points from clinical practice. In contrast to common practice in which contraceptives are discontinued at the moment of a VTE diagnosis, the thrombosis experts agreed to continue oral contraception (OC) during the anticoagulation treatment period. Also, experts reached consensus on treating patients with anticoagulation-associated abnormal uterine bleeding with tranexamic acid, although this is not supported by strong evidence from the literature. No consensus was reached on the optimal anticoagulant drug class. Conclusions: International experts' opinions on handling of contraceptives and management of anticoagulant-associated abnormal uterine bleeding in female VTE patients are divergent and management in clinical practice is heterogeneous. There is a great need of further studies on these topics. | ||
| 650 | 4 | |a Anticoagulants | |
| 650 | 4 | |a Contraception | |
| 650 | 4 | |a Haemorrhage | |
| 650 | 4 | |a Therapeutics | |
| 650 | 4 | |a Venous thromboembolism | |
| 700 | 1 | |a Schreiber, Karen |e VerfasserIn |0 (DE-588)1155487362 |0 (DE-627)1017756376 |0 (DE-576)501675426 |4 aut | |
| 700 | 1 | |a Stach-Jablonski, Ksenija |d 1982- |e VerfasserIn |0 (DE-588)1048422232 |0 (DE-627)781012724 |0 (DE-576)402237439 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Thrombosis research |d Amsterdam [u.a.] : Elsevier Science, 1972 |g 153(2017), Seite 101-107 |h Online-Ressource |w (DE-627)30671082X |w (DE-600)1500780-7 |w (DE-576)098253263 |x 1879-2472 |7 nnas |a Oral contraception and menstrual bleeding during treatment of venous thromboembolism expert opinion versus current practice : combined results of a systematic review, expert panel opinion and an international survey |
| 773 | 1 | 8 | |g volume:153 |g year:2017 |g pages:101-107 |g extent:7 |a Oral contraception and menstrual bleeding during treatment of venous thromboembolism expert opinion versus current practice : combined results of a systematic review, expert panel opinion and an international survey |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.thromres.2017.03.013 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0049384817302372 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180925 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1048422232 |a Stach-Jablonski, Ksenija |m 1048422232:Stach-Jablonski, Ksenija |d 60000 |d 61000 |e 60000PS1048422232 |e 61000PS1048422232 |k 0/60000/ |k 1/60000/61000/ |p 3 | ||
| 999 | |a KXP-PPN158128652X |e 3027143808 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"relHost":[{"pubHistory":["1.1972 -"],"note":["Gesehen am 15.11.23"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"30671082X","id":{"issn":["1879-2472"],"zdb":["1500780-7"],"eki":["30671082X"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1972","dateIssuedDisp":"1972-"}],"title":[{"subtitle":"vascular obstruction, hemorrhage and hemostasis","title_sort":"Thrombosis research","title":"Thrombosis research"}],"language":["eng"],"part":{"extent":"7","volume":"153","pages":"101-107","text":"153(2017), Seite 101-107","year":"2017"},"disp":"Oral contraception and menstrual bleeding during treatment of venous thromboembolism expert opinion versus current practice : combined results of a systematic review, expert panel opinion and an international surveyThrombosis research"}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"20 March 2017"}],"title":[{"title_sort":"Oral contraception and menstrual bleeding during treatment of venous thromboembolism","title":"Oral contraception and menstrual bleeding during treatment of venous thromboembolism","subtitle":"expert opinion versus current practice : combined results of a systematic review, expert panel opinion and an international survey"}],"person":[{"family":"Klok","given":"Erik","roleDisplay":"VerfasserIn","display":"Klok, Erik","role":"aut"},{"display":"Schreiber, Karen","role":"aut","roleDisplay":"VerfasserIn","family":"Schreiber","given":"Karen"},{"family":"Stach-Jablonski","given":"Ksenija","role":"aut","display":"Stach-Jablonski, Ksenija","roleDisplay":"VerfasserIn"}],"name":{"displayForm":["F.A. Klok, K. Schreiber, K. Stach, W. Ageno, S. Middeldorp, S. Eichinger, A. Delluc, M. Blondon, C. Ay"]},"note":["Available online 20 March 2017","Gesehen am 25.09.2018"],"physDesc":[{"extent":"7 S."}],"recId":"158128652X","id":{"doi":["10.1016/j.thromres.2017.03.013"],"eki":["158128652X"]}} | ||
| SRT | |a KLOKERIKSCORALCONTRA2020 | ||